Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/12/2012DE20321890U1 Impfstoffzusammensetzung The vaccine composition
03/12/2012DE20321889U1 Impfstoffzusammensetzung The vaccine composition
03/08/2012WO2012031258A1 Recombinant t-cell receptor ligands with covalently bound peptides
03/08/2012WO2012031103A2 Inhibitors of bcl-2
03/08/2012WO2012030759A1 Vacuole targeting peptides and methods of use
03/08/2012WO2012030735A1 Method and composition for crystallizing a family c gpcr
03/08/2012WO2012030720A1 Newcastle disease virus vectored herpesvirus vaccines
03/08/2012WO2012030268A1 Antiinfective plant nucleoprotein isolates
03/08/2012WO2012030202A1 Process for obtaining a collagen-rich extract from animal skins and resulting extract
03/08/2012WO2012030068A2 Polypeptide associated with the synthesis of 1-deoxynojirimycin, and a use therefor
03/08/2012WO2012030057A2 Medium composition for culturing self-activated lymphocytes and method for culturing self-activated lymphocytes using same
03/08/2012WO2012029954A1 Process for production of novel degalactosylated gc globulin
03/08/2012WO2012028945A2 Mutants of l-asparagine
03/08/2012WO2012028759A2 Anticaries compositions and probiotics/prebiotics
03/08/2012WO2012028741A1 Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof
03/08/2012WO2012028697A1 Affinity purification system based on donor strand complementation
03/08/2012WO2012028602A1 Solid phase synthesis of h(gly2)glp-2
03/08/2012WO2012028526A2 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
03/08/2012WO2012028525A2 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012WO2012028524A2 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012WO2012028309A2 Heavy metal reduction in planta
03/08/2012WO2012028172A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
03/08/2012WO2012027850A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012WO2012007324A3 Stabilized factor viii variants
03/08/2012WO2011158242A9 Pest-resistant plants
03/08/2012WO2011154751A3 Improvements in or relating to identification and eradication of insect pests
03/08/2012WO2011151515A3 Improved production of proteins in filamentous fungi
03/08/2012WO2011151512A3 Method for protein production in filamentous fungi
03/08/2012WO2011150133A3 Fibronectin based scaffold proteins having improved stability
03/08/2012WO2011147818A3 Production of metabolites
03/08/2012WO2011146518A3 Pegylated c-peptide
03/08/2012WO2011143575A3 smFRET WITH MEMBRANE PROTEINS
03/08/2012WO2011138032A3 Universal influenza vaccines and methods for their generation
03/08/2012WO2011130434A3 Antibodies that bind human cd27 and uses thereof
03/08/2012WO2011126811A3 High level expression of recombinant toxin proteins
03/08/2012WO2011123570A3 Methods for g-csf production in a pseudomonas host cell
03/08/2012WO2011123179A3 Alkylated sp-c peptoid compounds and related surfactant compositions
03/08/2012WO2001000832A9 Methods for making apo-2 ligand using divalent metal ions
03/08/2012US20120060240 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
03/08/2012US20120060239 Method For Secretory Production of Glycoprotein Having Human-Type Sugar Chain Using Plant Cell
03/08/2012US20120059153 Methods for preparing stable deoxygenated peg-hemoglobin conjugate solutions comprising an antioxidant
03/08/2012US20120059152 Protein substance having triple helix structure and manufacturing method therefor
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120059150 Methods for the production of apolipoproteins in transgenic plants
03/08/2012US20120059148 Non-naturally occurring lipoprotein particle
03/08/2012US20120059147 Method for site-selectively cleaving target nucleic acid
03/08/2012US20120059145 Stabilized bioactive peptides and methods of identification, synthesis, and use
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012US20120058944 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/08/2012US20120058933 Synthetic peptides and peptide mimetics
03/08/2012US20120058932 Active ingredient-peptide construct for extracellular concentration
03/08/2012US20120058909 Il-17 homologous polypeptides and therapeutic uses thereof
03/08/2012US20120058905 DNA Sequences Encoding Caryophyllaceae and Caryophyllaceae-Like Cyclopeptide Precursors and Methods of Use
03/08/2012US20120058538 Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
03/08/2012US20120058536 Polymer made of a primary amine functionalized polymer and a hemicellulose
03/08/2012US20120058526 Methods and Systems for Processing Sugar Mixtures and Resultant Compositions
03/08/2012US20120058522 Adenoviral va1 pol iii expression system for rnai expression
03/08/2012US20120058497 Diagnostic reagent for crohn's disease
03/08/2012US20120058495 Recombinant fragments and synthetic peptides of 17-kDa polypeptide useful in detecting Bartonella henselae
03/08/2012US20120058486 Genetic risk assessment technology for epithelial cancer involving gene-environment interaction between ercc5 and tobacco use
03/08/2012US20120058478 Multimers of s. solfataricus single-stranded dna-binding protein and methods of use thereof
03/08/2012US20120058476 Method Of Oligonucleotide Labeling Using Cycloaddition Reaction
03/08/2012US20120058344 Electronic Devices with Protein Layers
03/08/2012US20120058244 Maize multidrug resistance-associated protein polynucleotides and methods of use
03/08/2012US20120058202 Means and Method for Ovarian Cancer Prognosis
03/08/2012US20120058154 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
03/08/2012US20120058153 Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
03/08/2012US20120058146 Immunogens from uropathogenic escherichia coli
03/08/2012US20120058145 Method for producing virus from cell culture involving homogenization
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058136 NON-SPLICING VARIANTS OF gp350/220
03/08/2012US20120058131 Pta089 protein
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058117 Neuropilin-1 inhibitors
03/08/2012US20120058106 Novel cancer-associated antigen
03/08/2012US20120058090 Alimentary Protein-Based Scaffolds (APS) for Wound Healing, Regenerative Medicine and Drug Discovery
03/08/2012US20120058084 Interferon Alpha Carrier Prodrugs
03/08/2012US20120058083 Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012US20120055792 Msp nanopores and related methods
03/08/2012CA2846680A1 Solid phase synthesis of h[gly2]glp-2
03/08/2012CA2809890A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012CA2809573A1 Heavy metal reduction in planta
03/08/2012CA2809384A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stresstolerance
03/08/2012CA2809321A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
03/08/2012CA2809127A1 Newcastle disease virus vectored herpesvirus vaccines
03/08/2012CA2808793A1 Anticaries compositions and probiotics/prebiotics
03/08/2012CA2807836A1 Vacuole targeting peptides and methods of use
03/08/2012CA2807448A1 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
03/08/2012CA2807441A1 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012CA2807433A1 Method for producing a lipid particle, the lipid particle itself and its use
03/07/2012EP2426495A1 Kidney disease detection method that includes measurement of human megalin in urine
03/07/2012EP2426200A1 Protein-type electron mediator
03/07/2012EP2426196A1 Methods of making modular fusion protein expression products
03/07/2012EP2426144A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426142A2 Modified vaccinia virus strains for use in a diagnostic and therapeutic method
03/07/2012EP2426141A2 Method for preventing or treating M tuberculosis infection
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 2916